cSCC | Non-cSCC | ||
---|---|---|---|
N = 27 | N = 27 | ||
Age (years)a | 61.7 (27–77) | 61.3 (27–77) | p = 0.802 |
Gender (male) | 19 (70.4%) | 19 (70.4%) | p = 1 |
Years between Tx and first cSCCa | 5.4 (0.9–12.5) | – | – |
CMV status | p = 0.46 | ||
Negative | 12 (44.4%) | 9 (33.3%) | |
Positive | 15 (55.6%) | 17 (63.0%) | |
Unknown | – | 1 (3.7%) | |
Dialysis pre-transplantation | p = 0.783 | ||
Yes | 16 (59.3%) | 15 (55.6%) | |
No | 11 (40.7%) | 12 (44.4%) | |
ESRD diagnosis | p = 0.058 | ||
Polycystic kidney | 6 (22.2%) | 1 (3.7%) | |
Hypertension | 6 (22.2%) | 3 (11.1%) | |
Diabetic nefropathy | 1 (3.7%) | 6 (22.2%) | |
Glomerulonefritis | 3 (11.1%) | 6 (22.2%) | |
Other | 11 (40.7%) | 11 (40.7%) | |
% CD3a | 97.4 (92.4–99.5) | 98.0 (95.1–99.5) | p = 0.225 |
% CD4a | 73.0 (45.1–91.4) | 60.3 (34.8–80.7) | p = 0.000 |
% CD8a | 20.7 (5.8–46.2) | 32.8 (14.8–60.6) | p = 0.000 |